← FDA Drug Approvals (Drugs@FDA)

ESCITALOPRAM OXALATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS · Approved 2017-05-17

Drug application

FDA Application #
ANDA205619
Application type
Abbreviated New Drug Application (Generic)
Brand name
ESCITALOPRAM OXALATE
Generic name
ESCITALOPRAM OXALATE
Active ingredients
ESCITALOPRAM OXALATE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
AMNEAL PHARMS
Manufacturer
Amneal Pharmaceuticals LLC
First approval
2017-05-17

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown